LONDON/COPENHAGEN, Jan 31 (Reuters) - Catalent's CTLT.N Indiana plant in the United States has started filling injection pens for Novo Nordisk'sobesity drug Wegovy, the Danish drugmaker's CEO told ...
LONDON/COPENHAGEN, Jan 31 (Reuters) - Novo Nordisk's CEO Lars Fruergaard Jorgensen confirmed on Wednesday that Catalent's Indiana plant in the United States has started filling injection pens for its ...
LONDON, Nov 2 (Reuters) - Novo Nordisk is ramping up its in-house manufacturing capacity to fill injection pens for its diabetes drug Ozempic and for the European version of its hugely popular ...